Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6500
+0.0600 (3.77%)
NASDAQ · Last Trade: Dec 25th, 10:32 AM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors